IMC Chicago’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.57M Sell
7,500
-14,300
-66% -$3.59M ﹤0.01% 2809
2025
Q4
$6.2M Sell
21,800
-33,600
-61% -$10.5M ﹤0.01% 1576
2025
Q3
$17.1M Buy
55,400
+22,900
+70% +$7.17M 0.01% 853
2025
Q2
$10.2M Buy
32,500
+13,200
+68% +$3.81M ﹤0.01% 1005
2025
Q1
$5.07M Sell
19,300
-10,300
-35% -$2.79M ﹤0.01% 1224
2024
Q4
$7.73M Sell
29,600
-17,000
-36% -$4.28M ﹤0.01% 1040
2024
Q3
$10.8M Buy
46,600
+16,400
+54% +$3.37M 0.01% 782
2024
Q2
$6.09M Buy
30,200
+1,200
+4% +$216K ﹤0.01% 982
2024
Q1
$4.97M Buy
+29,000
New +$5.41M ﹤0.01% 970

Other funds holding PODD

IMC Chicago's PODD Position: Q4 2025 in Review

IMC Chicago sold out of Insulet (PODD) in Q4 2025, closing a stake of 22,959 shares — an estimated $7.18M sold.

IMC Chicago first reported a position in PODD in Q3 2025 and held it in 1 quarter. The position peaked at $7.09M in Q3 2025. 832 funds tracked by Wall St. Rank hold PODD as of Q4 2025.

  • IMC Chicago reported no remaining Insulet position as of Q4 2025 after selling out during the quarter.
  • IMC Chicago sold 22,959 Insulet shares in Q4 2025, an estimated $7.18M.
  • IMC Chicago first reported a position in Insulet in Q3 2025 and held it in 1 quarter.
  • IMC Chicago's Insulet position peaked at $7.09M in Q3 2025.
  • 832 funds tracked by Wall St. Rank held Insulet as of Q4 2025.

Based on IMC Chicago's 13F filing for Q4 2025, filed 29 Jan 2026.